Publications by authors named "Jing-ya Chen"

Nanomaterials have received increasing attentions owing to their potential hazards to the environment and human health; however, the multi-generational toxicity of graphene oxide under consecutive multi-generational exposure scenario still remains unclear. In the present study, Caenorhabditis elegans as an in vivo model organism was employed to explore the multi-generational toxicity effects of graphene oxide and the underlying mechanisms. Endpoints including development and lifespan, locomotion behaviors, defecation cycle, brood sizes, and oxidative response were evaluated in the parental generation and subsequent five filial generations.

View Article and Find Full Text PDF

CYP2B subfamily accounts for 2-10% of total hepatic CYP450 enzymes and participate in the metabolism of around 8% of clinical drugs. Borneol has been widely used in traditional Chinese medicine for thousands of years. There are many studies about borneol-induced promoting penetration role for a number of drugs through various physiologic barriers, whereas there is no report involved the effect of borneol on hepatic CYP2B.

View Article and Find Full Text PDF
Article Synopsis
  • Borneol, a traditional Chinese medicine, has been studied for its ability to enhance drug bioavailability and facilitate crossing the blood-brain barrier, raising concerns about drug interactions.
  • In a study with male Wistar rats, oral administration of borneol showed no significant effect on CYP2D expression, yet it increased CYP2D activity by up to 2.89 times compared to controls.
  • The results indicated that borneol may accelerate the elimination of dextromethorphan, suggesting possible metabolic interactions when taken with drugs metabolized by CYP2D.
View Article and Find Full Text PDF

Honokiol (HK) is the main bioactive compound isolated from the bark of Magnolia officinalis. The present work is the first to report the pharmacokinetics and distribution of HK and its two metabolites of hydroxylated HK conjugated with glucuronic and sulfuric acid (M1) and HK monoglucuronide (M2) in plasma, liver, kidney and brain following oral administration of HK (40 mg/kg) to healthy Wistar rats. The results showed that only HK but not M1 or M2 was found in brain.

View Article and Find Full Text PDF

Purpose: This study was undertaken to evaluate whole-brain functional connectivity changes related to auditory cortex in patients with left-sided sensorineural hearing loss (SNHL) using resting-state functional connectivity magnetic resonance imaging.

Method: Imaging was performed in 19 patients with left-sided SNHL and 35 individuals in the control group without SNHL. Data were collected and analyzed to map functional connectivity using the left/right primary auditory cortex as the region of interest to identify global differences between patients with SNHL and the control group.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the brain structure and activity changes in patients with unilateral hearing loss (UHL) compared to healthy individuals.
  • Researchers used advanced imaging techniques on patients with right-sided UHL and found significant decreases in gray matter volume in areas related to memory and auditory processing.
  • The analysis also revealed altered brain activity patterns, indicating that chronic UHL affects both brain morphology and functional connectivity.
View Article and Find Full Text PDF

Betel-quid use is associated with the risk of liver cirrhosis and hepatocellular carcinoma. The aim of the present work was to evaluate the impact of arecoline on human hepatic cytochrome P450 (CYP) enzymes in vitro and rat hepatic CYP enzymes, as well as the hepatic oxidative stress and liver injury of rats in vivo. The in vitro results indicated that arecoline hydrobromide (AH) has no significant effect on the activities of CYP2B, 2C9, 3A4, 1A2, 2E1 and 2D6 in human liver microsome (HLM).

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluates the efficacy and safety of sublingual immunotherapy (SLIT) in children aged 3-13 with allergies, specifically focusing on those as young as 3 years old.
  • The results showed that SLIT led to significant improvements in allergy symptoms, reduced asthma medication usage, and increased specific IgG4 levels, with no severe adverse events reported.
  • Both younger (under 5) and older children did not show differences in treatment outcomes, indicating SLIT is equally effective across this age range.
View Article and Find Full Text PDF
Article Synopsis
  • Sublingual immunotherapy (SLIT) using a Dermatophagoides farinae vaccine is effective in treating allergic conjunctivitis in a mouse model, although the exact mechanism is not fully understood.
  • The study showed that SLIT significantly reduced symptoms and histopathological changes similar to human allergic conjunctivitis, such as inflammation and elevated immunoglobulins.
  • SLIT treatment decreased total IgE and specific IgE levels while increasing IgG4 and Th1 cytokines, suggesting a shift from a Th2-dominated immune response, indicating its potential as an effective immunotherapy.
View Article and Find Full Text PDF